NASDAQ:DBVT

DBV Technologies S.A. Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$0.689

-0.0016 (-0.232%)

At Close: Apr 25, 2024

Currently predicting for Mon, 29 Apr 2024

Trading levels for DBVT

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	0.742	7.58 %
		R2	0.721	4.59 %
		R1	0.708	2.75 %
Current price:			0.689
	Support	S1	0.667	-3.22 %
		S2	0.654	-5.07 %
		S3	0.634	-8.06 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	0.85	23.59 %
		R2	0.770	11.69 %
		R1	0.700	1.54 %
Current price			0.689
	Support	S1	0.682	-1.12%
		S2	0.680	-1.36%
		S3	0.661	-4.12%

DBVT Predictions History

4 years ago
GoldenNugget predicted that DBVT for 2019-05-07 is going $9.83 (1.14%)

4 years ago
NameNotImportant predicted that DBVT for 2019-04-29 is going $10.27 (2.70%)

About DBV Technologies S.A.

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical t... DBVT Profile

Golden Star

Ticker	Date	Change	Price
MLI	Apr 19	11.73%	$52.28
LPLA	Apr 19	1.08%	$262.59
DOOR	Apr 18	0.274%	$131.39
LNG	Apr 17	1.63%	$156.81
FCN	Apr 16	3.70%	$207.62
ELV	Apr 16	6.45%	$506.97
AKR	Apr 05	5.14%	$16.53
ITCI	Apr 05	5.39%	$68.44
SARK	Mar 28	14.47%	$26.88
ARCC	Mar 25	2.53%	$20.12

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In